Michael Menzel
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Artificial intelligence in molecular pathology : Introduction and overview
Journal: Pathologie (Heidelberg, Germany)
Published: April 21, 2026
Correction: Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples.
Journal: British journal of cancer
Published: March 02, 2026
Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costing.
Journal: British journal of cancer
Published: October 31, 2025
Unveiling tumor heterogeneity by single cell RNA-sequencing: From basic considerations to clinical applications.
Journal: Seminars in cancer biology
Published: October 20, 2025
Whole Exome Sequencing on FHIR: Towards Adoption in Clinical Practice for Precision Oncology Pipelines.
Journal: Studies in health technology and informatics
Published: September 03, 2025
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples.
Journal: British journal of cancer
Published: July 16, 2025
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples.
Journal: British journal of cancer
Published: July 16, 2025
CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancer.
Journal: Communications biology
Published: November 04, 2024
Clinical Implementation of a High-Throughput Automated Comprehensive Genomic Profiling Test: TruSight Oncology 500 HT.
Journal: The Journal of molecular diagnostics : JMD
Published: July 24, 2024
Tumour mutational burden: clinical utility, challenges and emerging improvements.
Journal: Nature reviews. Clinical oncology
Published: July 23, 2024
Benchmarking whole exome sequencing in the German network for personalized medicine.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 20, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.
Journal: JCO precision oncology
Published: March 21, 2024
Last Updated: 09/26/2026